Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Acerus Pharmaceuticals Corporation
  6. News
  7. All News
    ASP   CA00444G1081

ACERUS PHARMACEUTICALS CORPORATION

(ASP)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about ACERUS PHARMACEUTICALS CORPORATION
08/23Acerus Announces Participation in HC Wainwright Conference
GL
08/12ACERUS PHARMACEUTICALS : Reports Acceptance of Part 36 Settlement Offer in Recipharm Litig..
MT
08/12Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation
GL
08/10ACERUS PHARMACEUTICALS : Q2 EPS US$0.00 Vs Loss $0.01 a Year Ago; Provides Update and Outl..
MT
08/10Acerus Reports Fiscal 2021 Second Quarter Financial Results
GL
08/09ACERUS : Q2 Earnings Snapshot
AQ
08/09Acerus Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter Ende..
CI
08/03Acerus to Report Q2-2021 Financial Results and Host Investor Call
GL
07/12ACERUS PHARMACEUTICALS : Says Legal Battle with Manufacturing Partner Recipharm Headed to ..
MT
07/12Acerus Provides Update on Litigation with Recipharm
GL
06/29ACERUS PHARMACEUTICALS : Reports Expansion of NATESTO Insurance Coverage in US
MT
06/29Acerus Announces New PBM Contract, Significantly Expanding NATESTO« Insurance Coverage ..
GL
06/29Acerus Announces New PBM Contract, Significantly Expanding Natesto« Insurance Coverage ..
CI
06/14Acerus Announces Voting Results for the 2021 Annual Meeting
GL
05/13Acerus Pharmaceuticals Seeks Acquisitions
CI
05/13ACERUS PHARMACEUTICALS : Reports First Quarter 2021 Financial Results
AQ
05/12Acerus Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended..
CI
05/10ACERUS PHARMACEUTICALS : In Co-Promotion Agreement with Amneal Pharmaceuticals for NATESTO
MT
05/10Acerus Pharmaceuticals Corporation Announces Co-Promotion Agreement with Amneal Pharmac..
CI
05/10Acerus Pharmaceuticals Announces Co-Promotion Agreement with Amneal Pharmaceuticals for..
GL
05/06ACERUS PHARMACEUTICALS : to Report Q1-2021 Financial Results and Host Investor Call
AQ
05/03ACERUS PHARMACEUTICALS : Announces closing of us$15 million secured loan facility
AQ
04/30ACERUS PHARMACEUTICALS : Secures US$15 Million Loan Facility
MT
04/30Acerus Pharmaceuticals Corporation Enters into $15 Million Subordinated Secured Loan Fa..
CI
04/30Acerus Announces Closing of US$15 Million Secured Loan Facility
GL
04/01ACERUS PHARMACEUTICALS : Buys Back All Remaining U.S. Rights for NATESTO From Aytu BioPhar..
MT
04/01AYTU BIOPHARMA : Sells US Rights to Low Testosterone Treatment Natesto to Acerus Pharma
MT
04/01Acerus Buys Back All Remaining U.S. Rights for NATESTO« From Aytu
GL
03/30UPDATE : Acerus Pharmaceuticals Jumps 10% as Expands NATESTO Distribution to 20 Countries
MT
03/30ACERUS PHARMACEUTICALS : Expands NATESTO Distribution to 20 Countries
MT
03/30Acerus Pharmaceuticals Corporation Signs Agreement Granting Maylen Farma the Exclusive ..
CI
03/30Acerus Announces Expansion of NATESTO« Distribution Worldwide
GL
03/26ACERUS PHARMACEUTICALS : Amends Credit Agreement
MT
03/26Acerus Pharmaceuticals Corporation Enters into an Amended Agreement Related to Its Exis..
CI
03/26Acerus Announces Amendment to Credit Agreement
GL
03/11ACERUS PHARMACEUTICALS : Reports Q4 Loss Per Share US$0.01
MT
03/11Acerus Reports Fourth Quarter and Full Year 2020 Financial Results
GL
03/11ACERUS : Q4 Earnings Snapshot
AQ
03/10Acerus Pharmaceuticals Corporation Auditor Raises 'Going Concern' Doubt
CI
03/10Acerus Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended Dec..
CI
03/04ACERUS PHARMACEUTICALS : to Report 2020 Financial Results and Host Investor Call
AQ
2020ACERUS PHARMACEUTICALS : Near 52 Week Lows Announces Waiver of Q4 Financial Covenant in Cr..
MT
2020ACERUS PHARMACEUTICALS : Raises C$13.2 Million as It Wraps Up Rights Offering
MT
2020ACERUS PHARMACEUTICALS : Announces Details of Previously Completed Rights Offering
BU
2020ACERUS PHARMACEUTICALS : Near 52 Week Lows As Says Completed Over-Subscribed Rights Offeri..
MT
2020ACERUS PHARMACEUTICALS : Announces Completion of Over-Subscribed Rights Offering
BU
2020ACERUS PHARMACEUTICALS : Q3 Loss Halves
MT
2020ACERUS : 3Q Earnings Snapshot
AQ
2020Acerus Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended..
CI
2020ACERUS PHARMACEUTICALS CORPORATION : RIGHTS ISSUE: 1 new share @ 0.025 CAD for 1.919841 ex..
FA
2020Acerus Pharmaceuticals Corporation Announces Appointment of Kevin Hickey as Senior Vice..
CI
2020ACERUS : 2Q Earnings Snapshot
AQ
2020Acerus Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter Ende..
CI
2020Acerus Pharmaceuticals Corporation Announces Resumption of NATESTO Shipments
CI
2020Acerus Pharmaceuticals Corporation Appoints Christopher Sorli as Chief Medical Officer
CI
2020AYTU BIOSCIENCE : Announces Expansion of NATESTO U.S. Commercial Team
AQ
2020Acerus Pharmaceuticals Corporation Announces Launch of Natesto«
CI
2020Acerus Announces Significant Improvement in NATESTO« Insurance Coverage in the United S..
CI
2020Acerus Pharmaceuticals Corporation Announces Impairment Charges for the First Quarter E..
CI
2020ACERUS : 1Q Earnings Snapshot
AQ
2020Acerus Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended..
CI
2020Acerus Pharmaceuticals Corporation Announces the Resignation of Norma Beauchamp as Dire..
CI
2020ACERUS PHARMACEUTICALS : to Report First Quarter 2020 Financial Results and Host Investor ..
BU
2020Acerus Pharmaceuticals Corporation Appoints Dr. Geoff Cotton to Its Board of Directors
CI
2020ACERUS PHARMACEUTICALS : Appoints Dr. Geoff Cotton to Its Board of Directors
PU
2020Acerus Pharmaceuticals Corporation Announces Publication of Results for Natesto« Sperma..
CI
2020Acerus Pharmaceuticals Corporation Receives Notice of Deficiency from Health Canada Reg..
CI
2020ACERUS PHARMACEUTICALS : Receives Notice of Deficiency From Health Canada Regarding Avanaf..
BU
2020ACERUS : 4Q Earnings Snapshot
AQ
2020Acerus Pharmaceuticals Corporation Announces Earnings Results for the Year Ended Decemb..
CI
2020Acerus Pharmaceuticals Corporation Auditor Raises 'Going Concern' Doubt
CI
2020Acerus Pharmaceuticals Corporation announced that it has received CAD 23.925712 million..
CI
2020Acerus Pharmaceuticals Corporation announced that it expects to receive CAD 23.925712 m..
CI
2020Acerus Announces Acceptance of Two Natesto« Clinical Studies for Presentation at the Am..
CI
2020Acerus Pharmaceuticals Corporation Announces Acceptance of NATESTO« Spermatogenesis Stu..
CI
1  2  3  4  5Next
Upcoming event on ACERUS PHARMACEUTICALS CORPORATION